PULSE BIOSCIENCES, INC. Quarterly Depreciation in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Pulse Biosciences, Inc. quarterly/annual Depreciation history and growth rate from Q1 2015 to Q3 2024.
  • Pulse Biosciences, Inc. Depreciation for the quarter ending September 30, 2024 was $100K, unchanged year-over-year.
  • Pulse Biosciences, Inc. Depreciation for the twelve months ending September 30, 2024 was $539K, a 4.6% decline year-over-year.
  • Pulse Biosciences, Inc. annual Depreciation for 2023 was $542K, a 21.4% decline from 2022.
  • Pulse Biosciences, Inc. annual Depreciation for 2022 was $690K, a 43.8% increase from 2021.
  • Pulse Biosciences, Inc. annual Depreciation for 2021 was $480K, a 11.6% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $539K $100K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $539K $100K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $539K $132K -$3K -2.22% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $542K $207K -$23K -10% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $565K $100K -$100K -50% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $665K $100K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $665K $135K -$25K -15.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $690K $230K +$63K +37.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $627K $200K +$100K +100% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $527K $100K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $527K $160K +$47K +41.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $480K $167K +$41K +32.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $439K $100K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $439K $100K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $439K $113K +$9K +8.65% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $430K $126K -$6K -4.55% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 $436K $100K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $436K $100K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $436K $104K -$58K -35.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $494K $132K +$40K +43.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 $454K $100K -$100K -50% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $554K $100K -$100K -50% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $654K $162K +$9K +5.88% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $645K $92K -$95K -50.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $740K $200K +$100K +100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $640K $200K +$175K +700% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $465K $153K +$129K +538% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $336K $187K +$164K +713% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $172K $100K +$75K +300% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $97K $25K +$1K +4.17% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $96K $24K +$2K +9.09% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $94K $23K +$3K +15% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 $91K $25K +$14K +127% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $77K $24K +$14K +140% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $63K $22K +$12K +120% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $51K $20K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $11K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $10K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $10K Jan 1, 2015 Mar 31, 2015 10-Q 2016-06-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.